IRA Episodes
Oct. 5, 2023
ICER’s Faux Updates
John O’Brien, President and CEO of the National Pharmaceutical Council, weighs in on ICER’s latest update that we are calling a “faux update”; The American Enterprise Institute has released its perspective on last year’s Inf…
None
Sept. 26, 2023
CMS Drug Price Negotiations
Kirsten Axelsen, Senior Policy Advisor at DLA Piper, says some of the fallout from CMS announcing price controls is already happening; the E&C Oversight and Investigations Subcommittee held a hearing on the IRA’s price-setti…
None